Mainz Biomed N.V. (MYNZ) EBITDA (2025 - 2026)
Mainz Biomed N.V. (MYNZ) EBITDA from Mar 31, 2025 to Mar 31, 2026. The TTM Mainz Biomed N.V. (MYNZ) EBITDA is -$2.41M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Mainz Biomed N.V. (MYNZ) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -6.59% |
Annual EBITDA change of Mainz Biomed N.V. (MYNZ)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.41M | -84.47% |
| 2025 | -$16M | -14.16% |
| 2024 | -$18M | -31.62% |
| 2023 | -$26M | +0.15% |
| 2022 | -$26M | +171.60% |
| 2021 | -$9.72M | +1350.75% |
| 2020 | -$670K | -16.25% |
| 2019 | -$800K | N/A |
Comparison Mainz Biomed N.V. (MYNZ) five years EBITDA CAGR with competitors
Mainz Biomed N.V. (MYNZ) five years EBITDA CAGR is 9.82%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | +644.92% |
| MEDP | Medpace Holdings Inc | 25.16% | +156.21% |
| ISPC | iSpecimen Inc | 25.14% | +155.99% |
| PSNL | Personalis Inc | 18.83% | +91.72% |
| WAT | Waters Corp | 17.45% | +77.74% |
| BNR | Burning Rock Biotech Ltd | 17.26% | +75.78% |
| ICLR | Icon Plc | 12.53% | +27.62% |
| IDXX | Idexx Laboratories Inc | 11.66% | +18.77% |
| CSTL | Castle Biosciences Inc | 10.29% | +4.76% |
| MTD | Mettler-Toledo International Inc | 9.87% | +0.48% |
| IQV | IQVIA Holdings Inc | 9.14% | -6.89% |
| RDNT | Radnet Inc | 8.38% | -14.61% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -22.45% |
| ILMN | Illumina Inc | 5.98% | -39.08% |
| A | Agilent Technologies Inc | 5.87% | -40.26% |
| GH | Guardant Health Inc | 5.67% | -42.25% |
| NTRA | Natera Inc | 3.35% | -65.87% |
| TWST | Twist Bioscience Corp | 2.84% | -71.09% |
| BDSX | Biodesix Inc | 2.43% | -75.21% |
| SHC | Sotera Health Company | 2.32% | -76.36% |
| QGEN | Qiagen NV | 2.21% | -77.54% |